Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)

This study has been completed.
Information provided by:
Baxter Healthcare Corporation Identifier:
First received: November 30, 2007
Last updated: July 21, 2009
Last verified: July 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2008
  Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 21, 2009